MYGN

#2997
Myriad Genetics Inc
4.9100 USD
+6.97%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
4.9100
4.9100
Rango anual
4.1050
8.5000
Cambio diario
+6.97%
Variación mensual
+5.36%
Variación en los últimos 6 meses
-40.63%
Cambio anual
-40.63%
Cierres anteriores
4.5900
Abrir
4.9100
Bid
Ask
Mínimo
4.9100
High
4.9100
Volumen
129
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 459.1251 M
  • Employee 2 700
  • Founded 1991
  • CEO Paul J. DiazPaul J. Diaz
  • Website www.myriad.com
  • Headquarter Delaware, United States
  • FIGI BBG000D9H9F1
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.56
Relación precio/flujo de caja
0.69

Myriad Genetics Inc

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity.

Noticias